• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CT与MR成像在肝细胞癌评估中的最新进展

Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma.

作者信息

Lee Jeong Min, Yoon Jeong-Hee, Joo Ijin, Woo Hyun Sik

机构信息

Department of Radiology and Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Liver Cancer. 2012 Jun;1(1):22-40. doi: 10.1159/000339018.

DOI:10.1159/000339018
PMID:24159569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3747553/
Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Accurate diagnosis and assessment of disease extent are crucial for proper management of patients with HCC. Imaging plays a crucial role in early detection, accurate staging, and the planning of management strategies. A variety of imaging modalities are currently used in evaluating patients with suspected HCC; these include ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, and angiography. Among these modalities, dynamic MRI and CT are regarded as the best imaging techniques available for the noninvasive diagnosis of HCC. Recent improvements in CT and MRI technology have made noninvasive and reliable diagnostic assessment of hepatocellular nodules possible in the cirrhotic liver, and biopsy is frequently not required prior to treatment. Until now, the major challenge for radiologists in imaging cirrhosis has been the characterization of small cirrhotic nodules smaller than 2 cm in diameter. Further technological advancement will undoubtedly have a major impact on liver tumor imaging. The increased speed of data acquisition in CT and MRI has allowed improvements in both spatial and temporal resolution, which have made possible a more precise evaluation of the hemodynamics of liver nodules. Furthermore, the development of new, tissue-specific contrast agents such as gadoxetic acid has improved HCC detection on MRI. In this review, we discuss the role of CT and MRI in the diagnosis and staging of HCC, recent technological advances, and the strengths and limitations of these imaging modalities.

摘要

肝细胞癌(HCC)是全球最常见的恶性肿瘤之一。准确诊断和评估疾病范围对于HCC患者的合理管理至关重要。影像学在早期检测、准确分期以及管理策略的规划中起着关键作用。目前,多种影像学检查方法用于评估疑似HCC的患者;这些方法包括超声、计算机断层扫描(CT)、磁共振成像(MRI)、核医学和血管造影。在这些检查方法中,动态MRI和CT被认为是用于HCC无创诊断的最佳影像学技术。CT和MRI技术的最新进展使得对肝硬化肝脏中的肝细胞结节进行无创且可靠的诊断评估成为可能,并且在治疗前通常无需进行活检。到目前为止,放射科医生在肝硬化影像学检查中的主要挑战一直是对直径小于2 cm的小肝硬化结节进行特征性描述。进一步的技术进步无疑将对肝脏肿瘤影像学产生重大影响。CT和MRI数据采集速度的提高使得空间和时间分辨率都得到了改善,从而能够更精确地评估肝脏结节的血流动力学。此外,新型组织特异性造影剂如钆塞酸的开发提高了MRI对HCC的检测能力。在本综述中,我们讨论了CT和MRI在HCC诊断和分期中的作用、最近的技术进展以及这些影像学检查方法的优缺点。

相似文献

1
Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma.CT与MR成像在肝细胞癌评估中的最新进展
Liver Cancer. 2012 Jun;1(1):22-40. doi: 10.1159/000339018.
2
Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma.肝癌影像学进展:诊断、分期和治疗效果评估:肝细胞癌的影像学诊断和分期。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):369-73. doi: 10.1007/s00534-009-0227-y. Epub 2009 Dec 8.
3
Advances of imaging for hepatocellular carcinoma.肝细胞癌的影像学进展。
Oncology. 2010 Jul;78 Suppl 1:46-52. doi: 10.1159/000315230. Epub 2010 Jul 8.
4
CT and MRI of hepatocellular carcinoma: an update.肝细胞癌的 CT 和 MRI:最新进展。
Expert Rev Anticancer Ther. 2010 Apr;10(4):507-19. doi: 10.1586/era.10.24.
5
Hepatocellular nodules in liver cirrhosis: MR evaluation.肝硬化中的肝细胞结节:磁共振成像评估
Abdom Imaging. 2011 Jun;36(3):282-9. doi: 10.1007/s00261-011-9692-2.
6
Diagnosis of hepatocellular carcinoma: newer radiological tools.肝细胞癌的诊断:新的影像学工具。
Semin Oncol. 2012 Aug;39(4):399-409. doi: 10.1053/j.seminoncol.2012.05.010.
7
Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.超顺磁性氧化铁增强 MRI 成像在肝硬化肝脏肝细胞癌无创成像诊断中的附加价值。
Invest Radiol. 2009 Dec;44(12):800-7. doi: 10.1097/RLI.0b013e3181bc271d.
8
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.使用钆塞酸二钠增强磁共振成像和扩散加权磁共振成像对肝炎后肝硬化患者小肝细胞癌(≤2.0 cm)诊断标准的验证
Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12.
9
Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.钆塞酸增强磁共振成像在鉴别 < 或 = 2cm 直径的小肝癌和动脉期增强假性病灶中的应用:特别强调肝胆期成像。
Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.
10
Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review.肝细胞癌的影像学诊断:最新进展综述
Diagnostics (Basel). 2023 Feb 8;13(4):625. doi: 10.3390/diagnostics13040625.

引用本文的文献

1
Differentiating Liver Metastases from Primary Liver Cancer: A Retrospective Study of Imaging and Pathological Features in Patients with Histopathological Confirmation.鉴别肝转移瘤与原发性肝癌:一项对经组织病理学确诊患者的影像学和病理特征的回顾性研究
Biomedicines. 2025 Jan 11;13(1):164. doi: 10.3390/biomedicines13010164.
2
Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma.甲胎蛋白、磷脂酰肌醇蛋白聚糖-3和激肽原-1作为肝细胞癌诊断的生物标志物。
Int J Clin Exp Pathol. 2024 Nov 15;17(11):383-395. doi: 10.62347/QSII4050. eCollection 2024.
3
Prediction of survival and analysis of prognostic factors for hepatocellular carcinoma: a 20-year of imaging diagnosis in Upper Northern Thailand.预测生存并分析肝癌的预后因素:泰国上北部 20 年的影像学诊断。
BMC Cancer. 2023 Nov 4;23(1):1063. doi: 10.1186/s12885-023-11429-6.
4
Evaluation of GALAD Score in Diagnosis and Follow-up of Hepatocellular Carcinoma after Local Ablative Therapy.GALAD评分在肝细胞癌局部消融治疗后诊断及随访中的评估
J Clin Transl Hepatol. 2023 Apr 28;11(2):334-340. doi: 10.14218/JCTH.2022.00013. Epub 2022 Jul 27.
5
Development and validation of MRI-based model for the preoperative prediction of macrotrabecular hepatocellular carcinoma subtype.基于MRI的大小梁型肝细胞癌亚型术前预测模型的开发与验证
Insights Imaging. 2022 Dec 21;13(1):201. doi: 10.1186/s13244-022-01333-1.
6
Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment.钆塞酸增强肝脏磁共振成像在局部治疗后肝细胞癌评估中的作用。
World J Gastroenterol. 2022 Jul 14;28(26):3116-3131. doi: 10.3748/wjg.v28.i26.3116.
7
Computed Tomography Techniques, Protocols, Advancements, and Future Directions in Liver Diseases.肝脏疾病的计算机断层扫描技术、方案、进展和未来方向。
Magn Reson Imaging Clin N Am. 2021 Aug;29(3):305-320. doi: 10.1016/j.mric.2021.05.002.
8
Clinical and contrast-enhanced image features in the prediction model for the detection of small hepatocellular carcinomas.用于检测小肝细胞癌的预测模型中的临床及增强影像特征
J Cancer. 2020 Oct 18;11(24):7166-7175. doi: 10.7150/jca.47245. eCollection 2020.
9
Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules.磁共振扩散峰度成像与常规扩散加权成像鉴别肝细胞癌与良性肝结节的比较
Contrast Media Mol Imaging. 2019 Jul 17;2019:2030147. doi: 10.1155/2019/2030147. eCollection 2019.
10
Liver Imaging Reporting and Data System in Patients at High Risk for Hepatocellular Carcinoma in the Memphis Veterans Affairs Population.孟菲斯退伍军人事务人群中肝细胞癌高危患者的肝脏影像报告和数据系统
Fed Pract. 2019 May;36(Suppl 3):S47-S52.

本文引用的文献

1
Dual-energy CT with single- and dual-source scanners: current applications in evaluating the genitourinary tract.双能 CT 单源和双源扫描:在评估泌尿生殖系统中的当前应用。
Radiographics. 2012 Mar-Apr;32(2):353-69. doi: 10.1148/rg.322115065.
2
Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients.肝细胞癌:移植前患者中弥散加权与对比增强磁共振成像的检测。
Hepatology. 2012 Jul;56(1):140-8. doi: 10.1002/hep.25681. Epub 2012 Jun 18.
3
Normal and altered three-dimensional portal venous hemodynamics in patients with liver cirrhosis.肝硬化患者正常和改变的三维门静脉血流动力学。
Radiology. 2012 Mar;262(3):862-73. doi: 10.1148/radiol.11110127.
4
Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).单独或联合应用扩散加权和钆塞酸增强 3T MR 成像诊断小肝转移瘤(≤1.5cm 直径)的准确性和敏感性。
Invest Radiol. 2012 Mar;47(3):159-66. doi: 10.1097/RLI.0b013e31823a1495.
5
Metal artefact reduction in gemstone spectral imaging dual-energy CT with and without metal artefact reduction software.宝石光谱成像能谱 CT 有和无金属伪影降低软件对金属伪影的降低作用。
Eur Radiol. 2012 Jun;22(6):1331-40. doi: 10.1007/s00330-011-2370-5. Epub 2012 Feb 4.
6
Diffusion-weighted MR imaging for liver lesion characterization: a critical look.用于肝脏病变特征描述的扩散加权磁共振成像:批判性审视。
Radiology. 2012 Feb;262(2):378-80. doi: 10.1148/radiol.11112417.
7
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study.凡德他尼治疗不可切除肝细胞癌患者的疗效:一项 II 期、随机、双盲、安慰剂对照研究。
J Hepatol. 2012 May;56(5):1097-1103. doi: 10.1016/j.jhep.2011.12.013. Epub 2012 Jan 13.
8
Multi-organ perfusion CT in the abdomen using a 320-detector row CT scanner: preliminary results of perfusion changes in the liver, spleen, and pancreas of cirrhotic patients.使用 320 排 CT 扫描仪进行腹部多器官灌注 CT:肝硬化患者肝脏、脾脏和胰腺灌注变化的初步结果。
Eur J Radiol. 2012 Oct;81(10):2533-7. doi: 10.1016/j.ejrad.2011.11.054. Epub 2012 Jan 5.
9
Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.肝细胞癌的超声、计算机断层扫描和磁共振成像:走向更好的治疗决策。
Oncology. 2011;81 Suppl 1:86-99. doi: 10.1159/000333267. Epub 2011 Dec 22.
10
Feasibility and accuracy of dual-source dual-energy CT for noninvasive determination of hepatic iron accumulation.双源双能 CT 无创测定肝脏铁沉积的可行性和准确性。
Radiology. 2012 Jan;262(1):126-35. doi: 10.1148/radiol.11110060. Epub 2011 Nov 21.